跳至主要内容
临床试验/NCT06025058
NCT06025058已完成不适用

Researcher-led Clinical Study to Evaluate the Effectiveness and Safety of the Application of Neopep-S-based Easy Dew MD Regen Cream in Patients Under Radiotherapy After Breast Tumor Resection

Eun-ji Kim2 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2022年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Transepidermal water loss

研究概览

简要总结

This clinical study is conducted prospectively for 3 months after medical device treatment. It is a comparative clinical study of the leading control group.

详细描述

Subject is a patient who has a tumor removed from the breast and is receiving radiotherapy at the lesion.

Subjects (and/or legal representatives) have agreed in writing to participate in the clinical study.

Perform a post-screening test. Evaluating the screening test results, meeting the selection criteria, and meeting the exclusion criteria.

Those who do not are registered for clinical research.

  • Control group: Physiogel Skin Stability Intensive Cream MD (10 people)
  • Study Group: EasyDew MD Regen Cream (20 people) The subjects of the clinical study are randomly assigned in a 2:1 ratio between the study group and the control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults over the age of 19
  • The tumor in the breast area is resected and radiotherapy is planned, performed, or Subjects with a history of irradiation
  • Decide to participate in this clinical study arbitrarily and in the written informed consent a person to whom

排除标准

  • When participating in a clinical study, the findings of radiation dermatitis in the area are shown
  • A person who shows signs of acute or chronic dermatological diseases
  • In situations where the requirements of a clinical study cannot be complied with
  • When the researcher's judgment determines that the participation of the study is inappropriate (e.g. Kelloid personality)

结局指标

主要结局

Transepidermal water loss

时间窗: before and one month, 3month after medical device application with GP SKin(machine/measuring the degree of moisture skin water loss)

Percutaneous moisture loss measured

次要结局

  • VSS(Before, after one month after application, 3 month after application)
  • Itching score(Before, after one month after application, 3 month after application)
  • BREAST-Q Survey Assessment(Before, after one month after application, 3 month after application)

研究者

发起方
Eun-ji Kim
申办方类型
Industry
责任方
Sponsor Investigator
主要研究者

Eun-ji Kim

Clinical Trial Manager

CGBio Inc.

研究点 (2)

Loading locations...

相似试验